Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Biomea Fusion Inc banner

Biomea Fusion Inc
NASDAQ:BMEA

Watchlist Manager
Biomea Fusion Inc Logo
Biomea Fusion Inc
NASDAQ:BMEA
Watchlist
Price: 1.7 USD -0.58%
Market Cap: $122.9m
Write Note Create Alert Ask AI
USD
Metric FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Revenue
0 0 0 0 0 0 0
Operating Expenses
(1.2m) (5.3m) (41.7m) (83.6m) (126.1m) (144.1m) (81.3m)
Selling, General & Administrative
(100k) (1.7m) (13.7m) (20.9m) (23.6m) (26m) (19.3m)
R&D
(1.1m) (3.7m) (28m) (62.7m) (102.5m) (118.1m) (62m)
Operating Income
(1.2m) (5.3m) (41.7m) (83.6m) (126.1m) (144.1m) (81.3m)
Net Interest Income (Expense)
0 0 100k 1.8m 8.9m 5.6m 1.9m
Non-Recurring Items
— — — — — — (2.2m)
Total Other Income
— — — — — — 19.9m
Pre-Tax Income
(1.2m) (5.3m) (41.6m) (81.8m) (117.3m) (138.4m) (61.8m)
Tax Provision
— — — — — 0 0
Income from Continuing Operations
(1.2m) (5.3m) (41.6m) (81.8m) (117.3m) (138.4m) (61.8m)
Net Income
(1.2m) (5.3m) (41.6m) (81.8m) (117.3m) (138.4m) (61.8m)
EPS (Diluted)
(0.04) (0.19) (1.74) (2.80) (3.44) (3.83) (1.18)
SENZA
SenzaGen AB

A growing testing platform nearing break-even but still reliant on external funding

Intrinsic Value Access required
INIT
Initiator Pharma A/S

A pre-revenue clinical biotech funding rising trial costs through external capital

Intrinsic Value Access required
BIIB
Biogen Inc

A cash-generative biotech transitioning from legacy MS to acquired growth platforms

Intrinsic Value Access required
ALNY
Alnylam Pharmaceuticals Inc

A rapidly scaled RNAi platform moving from R&D losses to product profitability

Intrinsic Value Access required

Continue BMEA Research

Summary
BMEA intrinsic value, competitors valuation, and company profile.
DCF Valuation
BMEA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BMEA stock valuation using valuation multiples.
Wall St Estimates
BMEA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BMEA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
ALPHA SPREAD
Follow us
Join 358,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.